Todos Med (TOMDF) Stock Price, News & Analysis

Company Overview

Todos Medical Ltd. is a development-stage precision medicine company that designs, develops and commercializes diagnostic assays and therapeutic technologies in the fields of oncology and infectious disease. Headquartered in Toronto with operational facilities in the United States, the company applies proprietary biomarker platforms to enable early disease detection, risk stratification and monitoring of treatment response. Its core focus is on next-generation liquid biopsy tests for multi-cancer screening as well as rapid point-of-care assays for viral infections.

In oncology, Todos Medical’s pipeline includes a blood-based screening test that analyzes circulating RNA and other molecular markers to identify tumors at an early, more treatable stage. This platform leverages advanced bioinformatics to distinguish cancerous signatures from benign conditions, with the aim of improving survival rates through earlier intervention. Alongside its cancer diagnostics business, the company has developed rapid antigen and antibody assays for COVID-19 detection, including a salivary test that has been deployed in clinical and public health settings under emergency use authorizations.

To bring its technologies to market, Todos Medical collaborates with contract research organizations, academic medical centers and commercial laboratories. The company seeks regulatory clearance for its assays in North America and Europe while establishing distribution agreements to serve hospitals, diagnostic labs and government health agencies. By integrating its diagnostic platforms into existing healthcare infrastructure, Todos Medical aims to support large-scale screening programs and personalized treatment pathways.

Led by a management team with extensive experience in biotechnology and diagnostic development, Todos Medical continues to expand its product portfolio and geographic reach. The company targets markets across North America, Europe and Latin America, positioning its innovative testing solutions to address growing demands for early disease detection and real-time infectious disease monitoring.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 2.22 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TOMDF
• CIK: 1645260
• Web: todosmedical.com
• Phone: 972732077259
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -0.01